Cascade Technologies Corp. (CSDT.OB) Subsidiary Appoints Seasoned VP for International Business Development

QualityStocks would like to highlight Spectral Molecular Imaging, a wholly-owned subsidiary of Cascade Technologies Corp. (OTCBB: CSDT). Spectral Molecular Imaging is a development-stage medical imaging device company, applying its proprietary hyperspectral-optical imaging technology — originally developed for satellite reconnaissance — to advance the early and accurate diagnoses of cancer and precancerous conditions.

In the company’s news yesterday,

Spectral Molecular Imaging announced the appointment of Dr. Sam Raz as the company’s vice president for International Business Development.

Dr. Daniel L. Farkas, chairman and CEO of Spectral Molecular, said the Dr. Raz’s experience and skill sets complement the company’s focus.

“Sam is an old friend and an exceptionally experienced and capable individual, who can greatly contribute to our company’s efforts,” Dr. Farkas stated in the press release. “The ambitious agenda that we have defined and are pursuing can only be made successful by bringing together the right talents, in a strategic way, and Dr. Raz is a pivotal new addition to our team in this regard. He will be managing our international connections, in research, clinical development and business alike, focusing geographically on Europe and Israel in his first year, since he is bringing to the task an unmatched set of existing relationships and expertise.”

Dr. Raz has a Bachelor of Science in environmental public health and bacteriology from UCLA, where he was awarded the American Hospital Association-Kellogg Foundation Award; the National Center for Health Services Research Award; the University of Pennsylvania National Health Care Management Center Award; the Los Angeles County Health and Hospital Department Distinction Award; the University of Michigan School of Public Health Crosby Award; and three UCLA scholarship awards.

In 2004, Dr. Raz served as president of Mind Fountain – Medical Technology Inc. He has also served as CEO of three start-ups: the Dynamic Memory External Fixator developed at Hadassah Medical Center, Jerusalem; the Female Incontinence Device developed at the most prestigious RAD Biomed Life Science Incubator; and the Skin Melanoma Detection and Cosmetic Assessment System developed at The Hebrew University of Jerusalem.

Dr. Raz also formed Advanced Dental Technologies in the UK and Germany to commercialize five dental products focusing on high quality dental implants and restorative accessories.

Previous endeavors also include the founding and position of CEO for The Variety Center, an Israeli national center for the advancement and diagnosis of children’s disabilities, where he developed 12 types of innovative intervention programs for handicapped children.

For the past six years, Dr. Raz served as CEO of Shiluv, a non-profit organization for the integration of Down Syndrome and normative preschool children. In addition, he was recently appointed the chairman of EMILI, a pre-school not-for-profit organization.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.